Skip to search formSkip to main contentSkip to account menu

ciglitazone

Known as: 5-(4-(1-methylcyclohexylmethoxy)benzyl)thiazolidine-2,4-dione, ciglitizone 
An agent belonging to the glitazone (thiazolidinedione) class of antidiabetic agents with antihyperglycemic activity. Ciglitazone also exerts anti… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Pulmonary fibrosis is a progressive life-threatening disease for which no effective therapy exists. Myofibroblasts are one of the… 
Highly Cited
2003
Highly Cited
2003
Peroxisome proliferator activator receptor-γ (PPARγ) is a nuclear receptor that controls the expression of several genes involved… 
Highly Cited
2001
Highly Cited
2001
Background—C-reactive protein (CRP) induces adhesion molecule expression by endothelial cells. However, the effects of CRP on… 
Highly Cited
1999
Highly Cited
1999
Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear receptor that functions as a transcription factor to mediate… 
Highly Cited
1999
Highly Cited
1999
15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is a bioactive prostanoid produced by dehydration and isomerization of PGD2, a… 
Highly Cited
1999
Highly Cited
1999
In osteoporosis, the bone marrow stroma osteogenic cell population declines and adipocyte numbers increase. We recently showed… 
Highly Cited
1998
Highly Cited
1998
Troglitazone, a thiazolidinedione derivative, is a widely used antidiabetic drug that binds and activates peroxisome proliferator… 
Highly Cited
1983
Highly Cited
1983
Effects of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone) on glucose and lipid…